Evidence map›Paper›PMID 36211199›Full record

ArticleJournal of scleroderma and related disorders2022

Extranodal localization of non-Hodgkin's lymphoma in systemic sclerosis: A diagnostic challenge and review of the literature.

Giorgio Galoppini, Beatrice Maranini, Giovanni Ciancio, Melissa Padovan, Gian Luca Casoni, Francesco Cavazzini, Roberta Gafà, Giovanni Lanza, Marcello Govoni

Abstract readCase Reports
In one paragraph

Article in Journal of scleroderma and related disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Giorgio GaloppiniRheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.ORCID https://orcid.org/0000-0003-1638-7310
Beatrice MaraniniRheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Giovanni CiancioRheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Melissa PadovanRheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Gian Luca CasoniPneumology Unit, Hospital of Rovigo, Rovigo, Italy.
Francesco CavazziniHematology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Roberta GafàPathology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Giovanni LanzaPathology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Marcello GovoniRheumatology Unit, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systemic sclerosis is associated with an increased incidence of malignancies, in particular solid neoplasms. Hematological cancers have been also observed in autoimmune diseases, though rarely present with lung involvement. The latter may be misdiagnosed in systemic sclerosis patients, due to the frequent concomitant interstitial lung disease. Case description: Here, we present the case of a 63-year-old man affected by systemic sclerosis presenting with an atypical lung imaging and splenomegaly, who was diagnosed with splenic marginal zone lymphoma, thus raising the suspicion of lung secondarism. We discuss the diagnostic challenge of differential diagnosis in interstitial lung presentation and briefly review the available literature on this topic. Conclusion: Several reports have demonstrated an increased risk of malignancy in patients with systemic sclerosis. Still, the lack of concretely defined guidelines for systemic sclerosis, along with systemic sclerosis multifaceted organ involvement at presentation, may challenge diagnosis and management. Here, we remark the importance of clinical work-up and a multidisciplinary approach in systemic sclerosis, to early detect and treat concomitant hematological malignancies, especially during the first years of the disease.

Indexed as

B-cell lymphomahematological malignanciessplenic marginal zone lymphomaSystemic sclerosis

Identifiers

PMID36211199
PMCPMC9537711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.